Cargando…
Analysis of Incentive Policies and Initiatives on Orphan Drug Development in China: Challenges, Reforms and Implications
OBJECTIVES: Rare diseases are a global public health issue with a more pressing situation in China. Unfortunately, the relevant research and development in this country are still in its infancy, leading to limited drug accessibility. In view of this, the Chinese government has taken a series of coun...
Autores principales: | Zhao, Zhiyao, Pei, Zhongyang, Hu, Anxia, Zhang, Yuhui, Chen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375655/ https://www.ncbi.nlm.nih.gov/pubmed/37501126 http://dx.doi.org/10.1186/s13023-023-02684-8 |
Ejemplares similares
-
Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016) -
Orphan drug incentives in the pharmacogenomic context: policy responses in the US and Canada
por: Gibson, Shannon, et al.
Publicado: (2015) -
Challenges in orphan drug development and regulatory policy in China
por: Cheng, Alice, et al.
Publicado: (2017) -
Incentives for orphan drug research and development in the United States
por: Seoane-Vazquez, Enrique, et al.
Publicado: (2008) -
Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)